Anxiolytics Flashcards

1
Q

Fear

A

Fear is a response to imminent, clear and present danger or threat.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anxiety

A

 Anxiety is a response to anticipated threat, which may be vague and ill-defined.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are fear and anxiety

A

 For both fear and anxiety, the threat may be real or perceived.
 For both fear and anxiety, the response include defensive behaviors, autonomic reflexes, arousal, corticosteroid production, and negative emotions.

 Under normal emotion: aroused, efficient, “fight or flight”.

 For a psychiatric state: interferes with activities of daily living, work and relationships

  • psychiatric state = ill-defined and chronic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Manifestation of anxiety states

A
• Psychological components: 
– Negative emotions: Worry, nervousness, unease. 
– Arousal. (continuously alert) 
– Lack of concentration. 
– Insomnia.
• Physical symptoms: 
– Tachycardia. 
– Shortness of breath. 
– Nausea. 
– Gastric acid hypersecretion. (ulcer) 
– Trembling.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Biochemical basis of anxiety

A
  1. Central and peripheral noradrenergic / adrenergic activation —> the “Flight or Fight” response
  2. Stress response —> Hypothalamus-pituitary-adrenal (HPA) axis —> secretion of stress hormones (cortisol).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Types of Anxiety disorders

A

• Generalized anxiety disorder (GAD):
– Excessive,uncontrollable worry over everyday matters.
– Interferes with daily functioning.
– Has both psychological and physical symptoms.
– Diagnosed when present for at least 6 months.
– Most common cause of disability in the workplace.

• Other anxiety and fear disorders: 
– Post-traumatic stress disorders (PTSD). 
– Phobias. 
– Panic disorder. 
– Obsessive compulsive disorders (OCD).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anxiety disorders: therapeutic rationale

A

• CNS depressant:
– Sedative –> causes sedation, relaxation.
– Hypnotic –> induces drowsiness and sleep, may have amnestic effects.
– Anxiolytic –> reduces anxiety.

Note: These actions are closely-related. The same drug can have more than one action depending on dose.
Eg:
– Low dose –> anxiolytic and sedative effects
– Higher doses –> hypnotic
– Even higher doses –> can cause anesthesia, used for surgery

Strength of CNS depression

1) Hypnotic
2) Sedative
3) Anxiolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Benzodiazepines

A

– Used as anxiolytics / sedatives: eg, diazepam, lorazepam, alprazolam.
– Used as hypnotics: eg, diazepam, triazolam, temazepam.
– Used as pre-anaesthetics: eg, diazepam, midazolam.
– May also have anti-convulsant effects: eg, diazepam, clonazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Benzodiazepines Used as anxiolytics / sedatives:

A

– Used as anxiolytics / sedatives: eg, diazepam, lorazepam, alprazolam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benzodiazepines – Used as hypnotics:

A

Used as hypnotics: eg, diazepam, triazolam, temazepam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Benzodiazepines – Used as pre-anaesthetics:

A

– Used as pre-anaesthetics: eg, diazepam, midazolam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Benzodiazepines – May also have anti-convulsant effects:

A

– May also have anti-convulsant effects: eg, diazepam, clonazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Benzodiazepines MOA

A

Binds to +ve allosteric site of GABA receptor and potentiate the effect of GABA actions by increasing the frequency of GABA-induced channel opening.

GABA—inhibitory transmitter in brain regions: acts via GABAA receptors Cl-channels. It causes the CL ions channel to open, leading to hyperpolarization of the cell.

BZD potentiates influx of CL ions leading to hyperpolarization, making cell more difficult to depolarize and therefore reduces neural excitability.
therefore neurons not firing.

Eg:

  • limbic system (alter mood)
  • Reticular activating system (causes drowsiness)
  • Motor cortex (relax muscles)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Short acting BZD

A

1) Midazolam (Anxiety. induction of general anesthesia, procedural sedation)
2) Triazolam (insomnia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Midazolam

A

Short acting BZD

1) Midazolam (Anxiety. induction of general anesthesia, procedural sedation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Triazolam

A

Short acting BZD

Triazolam (insomnia)

17
Q

Intermediate acting BZD

A

Alprazolam (Anxiety, panic disorder)

Clonazepam (panic disorder, seizure)

Lorazepam (Anxiety, insomnia, status, epilepticus)

Oxazepam ( Anxiety, Alcohol withdrawal syndrome)

Temazepam (Insomnia)

18
Q

Alprazolam

A

Intermediate acting BZD

Alprazolam (Anxiety, panic disorder)

19
Q

Clonazepam

A

Intermediate acting BZD

Clonazepam (panic disorder, seizure)

20
Q

Lorazepam

A

Intermediate acting BZD

Lorazepam (Anxiety, insomnia, status, epilepticus)

21
Q

Oxazepam

A

Intermediate acting BZD

Oxazepam ( Anxiety, Alcohol withdrawal syndrome)

Temazepam (Insomnia)

22
Q

Temazepam

A

Intermediate acting BZD

Temazepam (Insomnia)

23
Q

Long acting BZD

A

Chlordiazepoxide (Anxiety, Alcohol withdrawal syndrome)

Diazepam (Anxiety, Alcohol withdrawal syndrome, sedation, status, epilepticus, seizure, refractory seizure, adjunct skeletal muscle spasm)

Flurazepam (insomnia)

24
Q

Chlordiazepoxide

A

Long acting BZD

Chlordiazepoxide (Anxiety, Alcohol withdrawal syndrome)

25
Q

Diazepam

A

Long acting BZD

Diazepam (Anxiety, Alcohol withdrawal syndrome, sedation, status, epilepticus, seizure, refractory seizure, adjunct skeletal muscle spasm)

26
Q

Flurazepam

A

Long acting BZD

Flurazepam (insomnia)

27
Q

BZD ADR (Acute toxicity / overdose) + tx

A

– Can cause severe respiratory depression, especially used concurrently with alcohol.
– Treatment is by flumazenil, a benzodiazepine antagonist

28
Q

BZD ADR ( Side effects during use)

A

– Drowsiness, confusion, amnesia.
– Impaired muscle co-ordination (impairs manual skills).

• Tolerance and dependence:
– Depends on frequency of use. Therefore, tolerance develops faster for epilepsy than for use to induce sleep.
– Dependence can develop. Withdrawal symptoms include disturbed sleep, rebound anxiety, tremor and convulsions.
– Important to withdraw gradually.
– Has abuse potential.

29
Q

Barbiturates

A

–E.g.: pentobarbital, amobarbital
–Also potentiate GABA(A) mediated Cl- currents, but at a site distinct from benzodiazepines.
–Use as a sedative-hypnotic has largely been replaced by benzodiazepines due to barbiturates’ tendency to develop tolerance and dependence

30
Q

Long acting Barbiturates

A

Anticonvulsant: Eg, phenobarbital.

31
Q

Anticonvulsant Barbiturates

A
Long acting (1-2days) 
- phenobarbital
32
Q

Sedative & Hypnotic: Barbiturates

A

Short (3-8hrs) Sedative & Hypnotic:

Eg, pentobarbital and amobarbital.

33
Q

I.V induction of anesthesia Barbiturates

A

Ultrashort (20 min) I.V induction of anesthesia: Eg, Thiopental

34
Q

Barbiturates indication

A

Clinical indications based on duration of action

35
Q

Barbiturates ADR

A

–Severe withdrawal symptoms (~BZDs).

–Overdose may be fatal due to respiratory collapse.
–Flumazenil not effective for treating barbiturate overdose => coz bind to different site

–At anesthetic doses, barbiturates such as phenobarbital can directly open Cl- channels as well as block Na+ channels. (therefore stronger action)

36
Q

Buspirone

A

–A serotonin 5-HT1A receptor partial agonist. Also binds dopamine receptors.

–Indicated for GAD but anxiolytic effects takes 1-2 weeks.

–Lacks anticonvulsant and muscle relaxant properties.

37
Q

Propanolol

A

–A beta-adrenergic receptor antagonist (“betablocker”).

–Used for treating performance anxiety and social phobias.

–Reduces physical symptoms associated with adrenergic activation.

–Contraindicated in patients with asthma and heart conditions.

38
Q

Pregabalin

A

–GABA analogue, increases synaptic GABA —> GABA receptor mediated Cl- currents resulting in hyperpolarization.

–Also acts on voltage-gated Ca2+channels.
–Used to treat GAD, also has anticonvulsant effects.

–May be associated with emergence of worsening of suicidal thoughts. (DONT GIVE DEPRESSED PT)

39
Q

Hydroxyzine

A

–A first generation antihistamine with activities on serotonergic and α-adrenergic receptors.

–Anxiolytic effects attributed to antagonism of serotonin 5-HT2 receptors.
–Has low addictive potential compared to BZDs and barbiturates.
–Because of antihistamine activities, also helps with itching.